Your account is not claimed yet. You can sign up with ORCID to claim your account.

Josef Leibold

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Acute Myeloid Leukemia

Decision Making

Top Venues

Science (New York, N.Y.)

Cancer discovery

Sloan Kettering Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sloan Kettering Institute Jun 1o 2015

United States

Research Scholar :: Lowe lab

Publications

Phillip M Rappold, Lynda Vuong, Josef Leibold, Nicholas H Chakiryan, Michael Curry, Fengshen Kuo, Erich Sabio, Hui Jiang, Briana G Nixon, Ming Liu, Anders E Berglund, Andrew W Silagy, Eduardo A Mascareno, Mahdi Golkaram, Mahtab Marker, Albert Reising, Alexander Savchenko, John M Millholland, Ying-Bei Chen, Paul Russo, Jonathan A Coleman, Ed Reznik, Brandon J Manley, Irina Ostrovnaya, Vladimir Makarov, Renzo G DiNatale, Kyle A Blum, Xiaoxiao Ma, Diego Chowell, Ming O Li, David B Solit, Scott W Lowe, Timothy A Chan, Robert J Motzer, Martin H Voss, Abraham Ari Hakimi
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma. Cancer discovery 12 (10) (2022)
Marcus Ruscetti, Josef Leibold, Matthew J Bott, Myles Fennell, Amanda Kulick, Nelson R Salgado, Chi-Chao Chen, Yu-Jui Ho, Francisco J Sanchez-Rivera, Judith Feucht, Timour Baslan, Sha Tian, Hsuan-An Chen, Paul B Romesser, John T Poirier, Charles M Rudin, Elisa de Stanchina, Eusebio Manchado, Charles J Sherr, Scott W Lowe
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science (New York, N.Y.) 362 (6421) (2019)